Posted on 5/28/19
Evogene Reports First Quarter of 2019 Financial Results
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today its financial results for the first quarter . . .
Posted on 5/28/19
Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio
There are over 6,000 genetic disorders, and most don't have any regulatory-approved treatment options. That's discouraging, but there's reason for hope; gene therapies are in development . . .
Posted on 5/24/19
Pfizer Has Limited Downside
Summary10-year chart shows strong support for shares.2019 earnings guidance was increased after the announcement of Q1 numbers.Volume continues to diverge from price in the daily and . . .
Posted on 5/24/19
Better Buy: Johnson & Johnson vs. GlaxoSmithKline
Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline (NYSE:GSK) are two pharma stocks coveted by income investors for their top-notch dividends. Glaxo, for instance, sports one of the . . .
Posted on 5/23/19
Bayer Announces Five-Year Partnership with the World Federation of Hemophilia Humanitarian Aid Program
Today, Bayer announced a five-year partnership with the World Federation of Hemophilia (WFH) Humanitarian Aid Program, which will bring education, training, and Bayer's full portfolio of . . .
Posted on 5/23/19
Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019
SummaryPfizer announced that it had achieved positive top-line results from its phase 3 study using abrocitinb to treat patients with atopic dermatitis (eczema).Top-line results showed that . . .
Posted on 5/22/19
OncoSec Medical Incorporated Prices $11,000,000 Public Offering
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a late-stage cancer biotechnology company developing intratumoral gene-delivery immunotherapies, today announced the pricing of an underwritten public offering led by . . .
Posted on 5/22/19
Henry Schein Medical Expands Its SolutionsHub Portfolio
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., today announced the expansion of its web-based SolutionsHub. This resource features a full . . .
Posted on 5/22/19
White Oak Healthcare Finance Provides Financing for Dental 365
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC today announced it acted as sole lead arranger on the funding of a senior credit facility to finance the growth . . .
Posted on 5/22/19
Pfizer: Added Value For A Defensive Pharma Portfolio
SummaryOf the 6 largest pharmaceutical companies by market cap, Pfizer is the most balanced and with the shallowest patent cliff.Its best selling drugs are immune to . . .
Posted on 5/22/19
Better Buy: AbbVie vs. Pfizer
Over the last five years, AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) have both produced market-crushing returns for investors -- that is, when their top-notch dividends are figured . . .
Posted on 5/22/19
ADMA Biologics Closes $51.75 Million Public Offering
RAMSEY, N.J. and BOCA RATON, Fla., May 21, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company . . .
Posted on 5/22/19
Bioasis Closes Previously Disclosed Private Placement
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the . . .
Posted on 5/21/19
Prokaryotics Announces Exclusive Worldwide Licensing Agreement with MEDINA
Prokaryotics, Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into an exclusive licensing . . .
Posted on 5/21/19
Navitas Life Sciences Acquires KAI Research
Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc.KAI Research . . .
Posted on 5/21/19
Merck to Acquire Peloton Therapeutics
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc.
Posted on 5/21/19
Pfizer: A 3.5% Yield, But Lyrica's Patent Loss Keeps Me From Buying
SummaryPfizer Inc. is a global biopharma giant with a 3.5% dividend yield and a broad portfolio of therapies and consumer healthcare products.Pfizer has invested in R&D . . .
Posted on 5/21/19
Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved
SummaryPfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy.Vyndaqel and Vyndamax are the first drugs approved to treat ATTR-CM . . .
Posted on 5/21/19
PTC Therapeutics Announces First-Ever Winners of Its PRIORITY Program
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the three funding recipients from PRIORITY, an annual program to support outstanding clinical research by the rare genetic disorders . . .
Posted on 5/21/19
Insmed Announces Proposed Public Offering of Common Stock
Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock. In addition, Insmed . . .
Posted on 5/20/19
Concord Health Partners Completes Investment in Flexwise Health
SUMMIT, N.J.--(BUSINESS WIRE)--Concord Health Partners, a healthcare focused investment firm, has completed an investment in Flexwise Health, Inc., based in Brentwood, TN, a business support services . . .
Posted on 5/20/19
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
Becton, Dickinson and Company (NYSE: BDX) today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in . . .
Posted on 5/20/19
Where Will Pfizer Be in 5 Years?
Drug stocks have taken a hit lately as the market has started to worry about political pressures that may come to bear on pricing and affect . . .
Posted on 5/20/19
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
Despite some ups and downs, Johnson & Johnson's (NYSE:JNJ) pharmaceutical division consistently outperforms its peers in terms of branded drug sales. As a result, pharmaceutical sales . . .
Posted on 5/17/19
Valeritas Announces Reverse Stock Split
BRIDGEWATER, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, . . .

